22
|
2024 ASCRS ASOA MEETING GUIDE
ASCRS SUBSPECIALTY DAY
ASCRS GUCOMA DAY
9:09–9:17 a.m.
Intraoperative OCT
Paul Singh, MD
9:18–9:26 a.m.
Corneal hysteresis
Alessandro Jammal, MD, PhD
9:27–9:42 a.m.
Panel discussion/Q&A
9:43–9:51 a.m.
Glaucoma and AI
Robert Chang, MD
9:52–10:00 a.m.
Diagnostics of the future—genetics, DARC,
and beyond
Inas Aboobakar, MD
10:01–10:15 a.m.
Panel discussion/Q&A
10:15–10:45 a.m.
Break with exhibitors
10:45 a.m.–12:00 p.m.
Session III: Medications,
Lasers, & Lifestyle
The session includes strategies to treat glaucoma from life-
style modifications, medication use, and laser therapy, and will
also focus on the well-being of our patients and surgeons to
diminish risks over time.
Moderators: Deborah Ristvedt, DO, and Arsham Sheybani, MD
Part 1: Medications
10:45–10:53 a.m.
Uveitis and glaucoma: from the drops that
cause uveitis to the meds that treat it
Erin Sieck, MD
10:54–11:02 a.m.
Novel medications from formulation to
mechanism
Arthur Sit, MD, MS
11:03–11:11 a.m.
Pipeline drug delivery: will it change how we
treat our patients?
George Reiss, MD
Part 2: Lasers
11:12–11:20 a.m.
Lasers in pigment dispersion
Monica Ertel, MD, PhD
11:21–11:29 a.m.
Angle closure
Gus Gazzard, MD, FRCOphth, MA, MBBS
Part 3: Lifestyle
11:30–11:38 a.m.
FDA-approved options and how to maximize
their use
Leo Seibold, MD
11:39–11:47 a.m.
Glaucoma pipeline: drug delivery and lasers
Sarah Van Tassel, MD
11:48 a.m.–12:00 p.m.
Panel discussion/Q&A
12:00–1:00 p.m.
Lunch with exhibitors
1:00–2:15 p.m.
Session IV: Surgical Spotlight
Moderators: David Crandall, MD, and Sahar Bedrood, MD, PhD
What Procedure Would You Have?
1:00–1:04 p.m.
Case presentation
Sahar Bedrood, MD, PhD, and David Crandall, MD
